Personal tools

MCL coexpression mm9:1276: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0000073!7.54e-18!54;UBERON:0001049!1.46e-17!52;UBERON:0005068!1.46e-17!52;UBERON:0006241!1.46e-17!52;UBERON:0007135!1.46e-17!52;UBERON:0002020!2.39e-16!34;UBERON:0002346!1.08e-15!64;UBERON:0003075!1.08e-15!64;UBERON:0007284!1.08e-15!64;UBERON:0000955!2.73e-15!47;UBERON:0006238!2.73e-15!47;UBERON:0002616!1.28e-14!46;UBERON:0001017!1.71e-14!73;UBERON:0003056!1.95e-14!49;UBERON:0001016!5.36e-14!75;UBERON:0003528!7.02e-14!29;UBERON:0002791!7.02e-14!29;UBERON:0001893!7.02e-14!29;UBERON:0003080!7.60e-14!40;UBERON:0010371!1.35e-13!73;UBERON:0002780!2.10e-13!39;UBERON:0001890!2.10e-13!39;UBERON:0006240!2.10e-13!39;UBERON:0004121!9.84e-13!95;UBERON:0000924!9.84e-13!95;UBERON:0006601!9.84e-13!95;UBERON:0000956!4.96e-10!21;UBERON:0001869!4.96e-10!21;UBERON:0000203!4.96e-10!21;UBERON:0010314!6.44e-10!92;UBERON:0002619!8.68e-08!17
|ontology_enrichment_uberon=UBERON:0000073!7.54e-18!54;UBERON:0001049!1.46e-17!52;UBERON:0005068!1.46e-17!52;UBERON:0006241!1.46e-17!52;UBERON:0007135!1.46e-17!52;UBERON:0002020!2.39e-16!34;UBERON:0002346!1.08e-15!64;UBERON:0003075!1.08e-15!64;UBERON:0007284!1.08e-15!64;UBERON:0000955!2.73e-15!47;UBERON:0006238!2.73e-15!47;UBERON:0002616!1.28e-14!46;UBERON:0001017!1.71e-14!73;UBERON:0003056!1.95e-14!49;UBERON:0001016!5.36e-14!75;UBERON:0003528!7.02e-14!29;UBERON:0002791!7.02e-14!29;UBERON:0001893!7.02e-14!29;UBERON:0003080!7.60e-14!40;UBERON:0010371!1.35e-13!73;UBERON:0002780!2.10e-13!39;UBERON:0001890!2.10e-13!39;UBERON:0006240!2.10e-13!39;UBERON:0004121!9.84e-13!95;UBERON:0000924!9.84e-13!95;UBERON:0006601!9.84e-13!95;UBERON:0000956!4.96e-10!21;UBERON:0001869!4.96e-10!21;UBERON:0000203!4.96e-10!21;UBERON:0010314!6.44e-10!92;UBERON:0002619!8.68e-08!17
|tfbs_overrepresentation_for_novel_motifs=0.491922,0.217198,1.17362,0.535892,0.346849,1.35778,0.645383,0.247459,0.257202,0.0835344,0.599767,0.632897,0.247704,0.6581,0.364314,0,0.856992,0.338549,0.656199,0.143775,0.426133,0.108444,0.657163,0.345236,0.472505,0.686615,0.223823,0.572827,0.394364,1.0231,0.558142,0.960397,0.336199,0.589948,0.364821,0.335531,0.871288,0.629145,1.48701,1.37841,0.342638,0.56353,0.0995018,0.366415,0.368882,0.524258,0.77511,0.589246,0.284064,0.397446,0.839084,0.714419,0.517905,1.10437,1.12205,0.66551,0.406788,0.619643,0.21472,1.59383,0.939962,0.724164,0.742129,0.827522,0.677043,0.869046,1.2599,1.61148,0.935192,1.46355,0.444872,0.70565,1.21401,1.156,0.208101,0.19692,0.204132,0.763395,0.922432,0.430551,2.01946,0.874787,0.722675,0.676326,1.03903,0.198949,0.0610418,1.02367,1.83587,1.77427,1.33021,1.04409,0.973447,0.35304,0.2995,0.769162,1.27104,0.976308,0.775372,0.160254,0.326561,0.960112,1.08669,0.839694,0.838613,1.38336,0.8998,0.585058,0.435642,0.428007,0.484547,1.0885,0.431734,0.605144,1.33732,0.340765,0.247162,0.53982,0.858327,0.322606,1.16147,0.805995,0.688501,0.762461,1.39185,0.926209,0.65384,0.966541,1.25836,0.937314,1.06946,0.52828,1.2285,0.679647,1.35909,0.106956,1.25097,0.564999,1.30952,2.14327,1.74232,1.26465,0.700956,0.971067,0.831964,0.564002,0.778321,2.10357,0.503174,0.920761,0.540361,0.667976,1.10596,0.287383,0.678689,1.18867,0.71546,0.376898,1.22669,0.500417,1.31911,1.03816,0.926663,0.482185,1.93554,0.671017,0.325308,0.63125,0.131395
}}
}}

Revision as of 19:39, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr11:115489574..115489612,-p3@Slc25a19
Mm9::chr8:124967535..124967559,+p1@9330133O14Rik
Mm9::chr8:75072293..75072323,+p@chr8:75072293..75072323
+
Mm9::chr9:112136737..112136755,+p2@2900079G21Rik
Mm9::chr9:112136761..112136817,+p1@2900079G21Rik
Mm9::chrX:156065014..156065035,+p25@Sh3kbp1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CNS neuron (sensu Vertebrata)1.05e-1123
neuroblast (sensu Vertebrata)1.05e-1123

Uber Anatomy
Ontology termp-valuen
regional part of nervous system7.54e-1854
neural tube1.46e-1752
neural rod1.46e-1752
future spinal cord1.46e-1752
neural keel1.46e-1752
gray matter2.39e-1634
neurectoderm1.08e-1564
neural plate1.08e-1564
presumptive neural plate1.08e-1564
brain2.73e-1547
future brain2.73e-1547
regional part of brain1.28e-1446
central nervous system1.71e-1473
pre-chordal neural plate1.95e-1449
nervous system5.36e-1475
brain grey matter7.02e-1429
regional part of telencephalon7.02e-1429
telencephalon7.02e-1429
anterior neural tube7.60e-1440
ecto-epithelium1.35e-1373
regional part of forebrain2.10e-1339
forebrain2.10e-1339
future forebrain2.10e-1339
ectoderm-derived structure9.84e-1395
ectoderm9.84e-1395
presumptive ectoderm9.84e-1395
cerebral cortex4.96e-1021
cerebral hemisphere4.96e-1021
pallium4.96e-1021
structure with developmental contribution from neural crest6.44e-1092
regional part of cerebral cortex8.68e-0817


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}